Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Michigan marijuana sales revenue in 2025 declined for the first time since the market opened in December 2019. Michigan ...

Brigitte Amiri, deputy director of the Reproductive Freedom Project at the ACLU, said in a statement that while funding has ...

Company enters 2026 with over $70 million in cash, two positive Phase 2 programs, FDA Fast Track Designation and runway well into 2027 ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ('Psyence BioMed” or the 'Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...

Republican House Speaker Matt Hall said affordability is going to be the focus for the Michigan House in 2026, with ...

The aircraft used in the US military’s first strike on an alleged drug boat in the Caribbean, a strike which has drawn ...

FDA staffers and outside experts worry the program runs afoul of legal, ethical and scientific standards used to review new ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...

San Antonio's District 1 and Corazón Ministries start a Pilot Program for safe needle disposal to address drug overdoses.